ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission.
Precisely how anti-ADAMTS13 autoantibodies, or antibody subsets, cause ADAMTS13 deficiency (ADAMTS13 activity generally < 10%) has not been formally.
A deficiency in ADAMTS13 (A Disintegrin And Metalloprotease with field from ADAMTS13 and inhibitory antibodies to immune complexes.
Antibody to ADAMTS13 is not usually detected in patients with congenital deficiency. Most TTP cases are idiopathic and are associated antibodies to.
We evaluated prevalence of anti-ADAMTS13 antibodies in 59 patients with thrombotic microangiopathies (TMAs) and in patients with immunologic or.
Presenting ADAMTS13 antibody and antigen levels predict prognosis in immune- mediated thrombotic thrombocytopenic purpura. Ferras Alwan, Chiara.